These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38702533)

  • 1. Promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy.
    Chiba M; Kimura K
    J Gastroenterol; 2024 Jul; 59(7):641-642. PubMed ID: 38702533
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to "promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy".
    Naganuma M
    J Gastroenterol; 2024 Jul; 59(7):643. PubMed ID: 38739201
    [No Abstract]   [Full Text] [Related]  

  • 3. Appendiceal Orifice Inflammation in Severe Ulcerative Colitis and Its Resolution With Infliximab and Plant-based Diet as First-line Therapy.
    Chiba M; Ishii H; Sageshima M; Iwabuchi A
    Inflamm Bowel Dis; 2021 Oct; 27(11):e138-e139. PubMed ID: 34291790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab versus cyclosporine for severe ulcerative colitis refractory to steroids: A protocol for systematic review and meta-analysis.
    Wu D; Yang Z; Zhao C; Yao L
    Medicine (Baltimore); 2018 Oct; 97(41):e12657. PubMed ID: 30313056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inpatient infliximab is ineffective at preventing colectomy for steroid refractory extensive colitis.
    Andrew RE; Lauria A; Puleo FJ; Berg A; Stewart DB
    J Surg Res; 2017 Nov; 219():18-24. PubMed ID: 29078879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab rescue therapy in acute severe ulcerative colitis: more does not equal better.
    Kedia S; Ahuja V
    Lancet Gastroenterol Hepatol; 2024 Nov; 9(11):966-967. PubMed ID: 39236737
    [No Abstract]   [Full Text] [Related]  

  • 7. Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis.
    Choy MC; Seah D; Faleck DM; Shah SC; Chao CY; An YK; Radford-Smith G; Bessissow T; Dubinsky MC; Ford AC; Churilov L; Yeomans ND; De Cruz PP
    Inflamm Bowel Dis; 2019 Jun; 25(7):1169-1186. PubMed ID: 30605549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe Henoch-Schönlein purpura complicating infliximab therapy for ulcerative colitis.
    Laresche C; Locatelli F; Biver-Dalle C; Nachury M; Heyd B; Koch S; Aubin F
    Cutis; 2017 Jan; 99(1):E20-E22. PubMed ID: 28207014
    [No Abstract]   [Full Text] [Related]  

  • 9. A pharmacokinetic approach to model-guided design of infliximab schedules in ulcerative colitis patients.
    Pérez-Pitarch A; Ferriols-Lisart R; Alós-Almiñana M; Mínguez-Pérez M
    Rev Esp Enferm Dig; 2015 Mar; 107(3):137-42. PubMed ID: 25733037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.
    Järnerot G; Hertervig E; Friis-Liby I; Blomquist L; Karlén P; Grännö C; Vilien M; Ström M; Danielsson A; Verbaan H; Hellström PM; Magnuson A; Curman B
    Gastroenterology; 2005 Jun; 128(7):1805-11. PubMed ID: 15940615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoalbuminemia and Bandemia Predict Failure of Infliximab Rescue Therapy in Acute Severe Ulcerative Colitis.
    Syal G; Robbins L; Kashani A; Bonthala N; Feldman E; Fleshner P; Vasiliauskas E; McGovern D; Ha C; Targan S; Melmed GY
    Dig Dis Sci; 2021 Jan; 66(1):199-205. PubMed ID: 32170473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
    Yamamoto-Furusho JK; Uzcanga LF
    Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of outcomes of cyclosporine A and infliximab for steroid-refractory acute severe ulcerative colitis.
    Dai C; Jiang M; Huang YH
    J Gastroenterol Hepatol; 2021 Jul; 36(7):2024-2025. PubMed ID: 33880817
    [No Abstract]   [Full Text] [Related]  

  • 14. High Remission Rate with Infliximab and Plant-Based Diet as First-Line (IPF) Therapy for Severe Ulcerative Colitis: Single-Group Trial.
    Chiba M; Tsuji T; Nakane K; Tsuda S; Ishii H; Ohno H; Obara Y; Komatsu M; Tozawa H
    Perm J; 2020 Nov; 24():1-10. PubMed ID: 33482946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Treatment Response Predicts Outcome in Paediatric Ulcerative Colitis: GASTROENTEROLOGY: INFLAMMATORY BOWEL DISEASE.
    Gasparetto M; Wong-Spracklen V; Torrente F; Howell K; Brennan M; Noble-Jamieson G; Heuschkel R; Zilbauer M
    J Pediatr Gastroenterol Nutr; 2018 Aug; 67(2):217-220. PubMed ID: 30044356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant 5-Aminosalicylate Therapy in Moderate-to-Severe Ulcerative Colitis Patients Escalated to Infliximab Is Not Beneficial.
    Balram B; Joshi H; Wong K; Kroeker KI; Dieleman LA; Halloran BP; Baumgart DC; Peerani F
    Dig Dis Sci; 2021 Nov; 66(11):3985-3992. PubMed ID: 33184796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing paediatric acute severe ulcerative colitis according to the 2011 ECCO-ESPGHAN guidelines: Efficacy of infliximab as a rescue therapy.
    Aloi M; D'Arcangelo G; Capponi M; Nuti F; Vassallo F; Civitelli F; Oliva S; Pagliaro G; Cucchiara S
    Dig Liver Dis; 2015 Jun; 47(6):455-9. PubMed ID: 25733340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Accelerated Induction Strategy of Infliximab for Ulcerative Colitis in Hospitalized Patients at a Tertiary Care Center.
    Govani SM; Berinstein JA; Waljee AK; Stidham RW; Higgins PDR; Hardiman KM
    Dig Dis Sci; 2020 Jun; 65(6):1800-1805. PubMed ID: 31748921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ulcerative colitis endoscopic index of severity is associated with long-term prognosis in ulcerative colitis patients treated with infliximab.
    Saigusa K; Matsuoka K; Sugimoto S; Arai M; Kiyohara H; Takeshita K; Mizuno S; Mori K; Nanki K; Takeshita T; Nakazato Y; Yajima T; Naganuma M; Hisamatsu T; Ogata H; Iwao Y; Kanai T
    Dig Endosc; 2016 Sep; 28(6):665-70. PubMed ID: 26997640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study.
    Danese S; Colombel JF; Lukas M; Gisbert JP; D'Haens G; Hayee B; Panaccione R; Kim HS; Reinisch W; Tyrrell H; Oh YS; Tole S; Chai A; Chamberlain-James K; Tang MT; Schreiber S;
    Lancet Gastroenterol Hepatol; 2022 Feb; 7(2):118-127. PubMed ID: 34798038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.